Last updated: 2026-09-07 16:35:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Bionano Genomics, Inc. (BNGO) operates in the LABORATORY ANALYTICAL INSTRUMENTS sector and is listed on NASDAQ. The stock is currently priced at $1.21, with a market capitalization of $14.13M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.00 to $5.50. This page covers its latest market performance, valuation, price trends and company information.
$14.13M | |
$1.25 | |
$9,414.00 | |
$1.00 | |
$1.24 | |
171.54K | |
138.08K | |
-- | |
$5.50 | |
$1.00 | |
-- | |
-- |
Bionano Genomics, Inc. (BNGO) last closed at $1.24 as of 2026-09-04 23:56:00, unchanged from the previous close of $1.24.
During the latest regular trading session, BNGO traded between $1.00 and $9,414.00, with a volume of 171.54K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, Bionano Genomics, Inc. (BNGO) moved from $1.21 to $1.21, representing a decline of 0.41% ($0.00).
The stock traded between $1.15 and $1.28 during the period. The latest price is near the middle of the 7-day range, indicating range-bound.
The average daily volume was 200.53 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 4.6%
BNGO is currently trading at $1.21, placing it 4.6% of the way from its 52-week low of $1.00 to its 52-week high of $5.50. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.
| Industry | LABORATORY ANALYTICAL INSTRUMENTS |
| Employees | 97 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Bionano Genomics, Inc. (BNGO) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.